Adidas Record Quarter Meets a Wall of Cost Pressures — and a CEO ...
SAP's Regulatory Reprieve Masks a Deeper Investor Debate Over ...
DroneShield's Growth Paradox: Revenue Surges While the Market ...
Amazon's Cloud Engine Is Running Hot — But the AI Bill Is Coming ...
Commerzbank s Delicate Dance: A CEO s Olive Branch Meets a Hardened ...
Silver's Defining Test: A 55-Dollar Floor That Could Decide the ...
Rheinmetall's Autonomy Contract Lands at a Pivotal Moment for ...
Xiaomi's Memory-Chip Squeeze Puts a Hard Cap on Its EV Momentum ...
Memory s Middleman: How One Shanghai Listing Upended Micron s ...
BYD's Balancing Act: Record Exports and a Robot Reveal Collide ...
Tilray s Split Personality: Wall Street Can t Agree on the Cannabis ...
Stryker's Guidance Tightening Leaves Investors Unimpressed Despite ...
Equinox Gold's Merger Milestone Meets a Market Cold Shoulder
Siemens Energy Sits in No-Man's Land as Bulls and Bears Battle ...
Adesso's August 14 Report Looms as the Ultimate Test for a Stock ...
Infineon's Dresden Milestone Meets Its Moment of Truth: Can 62 ...
JinkoSolar s Regulatory Lifeline Meets Wall Street s Cold Shoulder ...
Heidelberg Materials Faces Margin Squeeze as Energy Costs Bite ...
Almonty Industries: Wolfram Producer's Record Quarter Collides ...
From Rugby Pitch to Taiwan: How a German Triathlete's Workout ...
East German Leaders Threaten to Derail Berlin's Pension Overhaul ...
IperionX's Cash Position Hits Record High While Its Share Price ...
Shell's Record Quarter Meets a Governance Handover: Buybacks ...
Canamera Energy Metals: Oversold Bounce Meets a Pipeline of Pending ...
Shell's August Calendar Gets Crowded: Dividend Cut-Off Buyback ...
Redwood AI's Two-Front Problem: A Stalled Takeover and a Silent ...
Vulcan Energy s €2.2 Billion Lionheart Backing Can t Lift a ...
Kraken Robotics: A $327 Million Order Book Meets a Share Price ...
Metallium's Moment of Truth: A Tuesday Webinar Against a 67% ...
EU Expands Allergen Labeling Rules: 81 Fragrance Ingredients ...
Redcare Pharmacy's Margin Milestone Fails to Shield Shares From ...
Shell's Busiest Fortnight in Years: A $720M Cyprus Exit a $13.6B ...
Branicks Puts 15% Price Tag on Survival as Creditors Sign Off ...
Novo Nordisk's Failed Heart Drug Trial Puts Its Diversification ...